Transplant Infectious Disease

Article	Citations
	96
	56
	55
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T‐Cell Leukemia/Lymphoma in the Pre‐Letermovir Era	42
Vaccine protection and how we measure it	39
Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient	35
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?	34
Successful treatment of Rhodococcus lung abscess and empyema thoracis in a heart transplant recipient	31
Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient	31
Nitazoxanide for Enterocytozoon bieneusi intestinal microsporidiosis	30
Neuroinvasive West Nile virus infection in solid organ transplant recipients	28
Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior tre	27
Pathogen‐agnostic immune biomarkers that predict infection after solid organ transplantation	27
Outcome of Pneumocystis pneumonia in transplant and non‐transplant HIV‐negative immunocompromised patients	25
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review	25
Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant	25
Perspectives on biovigilance and transmission of infection of donor origin in deceased organ donation—The evolving scenario in the United Kingdom	23
Atypical pneumonia testing in transplant recipients	22
Short‐term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors	22
1,3‐β‐D‐glucan testing for nocardiosis in solid organ transplant recipients	21
SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin	21
Utility of microbiologic testing in surveillance bronchoscopy following lung transplantation: A retrospective cohort study	21
Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study	20
Research Advice for Early Career Transplant Infectious Disease Clinicians	19
Impact of machine perfusion on transplant infectious diseases: New challenges and opportunities	19

Metagenomics in infectious disease diagnostics: Toward best‐use practices to optimize actionable results	19
Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review	19
Cover Image	19
The Journal in 2024: Reflections and Thanks for Our Reviewers	19
Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective	19
The American Association of Tissue Banks tissue donor screening for Mycobacterium tuberculosis—Recommended criteria and literature review	19
Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study	18
Ultrasound for management of left ventricular assist device driveline infections: A single‐center experience	17
Surveillance for donor‐derived infections in Australia	16
A glimpse into my journey: Lung transplantation for COVID‐19	16
Evaluation of Titer‐Proven Response Rates of Pediatric Hepatitis B‐Combination Vaccines in Adult Hematopoietic Cell Transplant Recipients	16
Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program	16
Perspectives on donor‐derived infections from the Notify Library	15
Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients	15
Into the unknown: Diagnosing mysterious brain lesions	15
ChatGPT may help in counseling on strategies for safe living following solid organ transplantation	14
Antifungal stewardship in solid‐organ transplantation: What is needed?	14
The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research	13
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients	13
Breakthrough COVID‐19 after SARS‐CoV‐2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy	13
Could cell‐free DNA and host biomarkers assist in antimicrobial stewardship with organ transplant recipients?	13
The outcomes of Clostridioides difficile infection in inpatient liver transplant population	13
Real‐world experience of tixagevimab‐cilgavimab pre‐exposure prophylaxis in orthotopic heart transplant recipients	12
SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps	12
Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Di	12
Cytomegalovirus‐Induced Arterial Intimal Fibrosis in the Kidney Transplant	12
Omicron breakthrough infection in a kidney‐transplant patient given pre‐exposition casirivimab and imdevimab monoclonal antibodies	12
Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis	12
Role of cytomegalovirus specific cell‐mediated immunity in the monitoring of cytomegalovirus infection among living donor liver transplantation adult recipients: A single‐center experience	12
Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care	12
Donor‐derived infections: The Swiss perspective	12
Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans	12
Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients	11
Trichophyton onychomycosis and deep dermatophytosis in a post‐heart transplant patient	11
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases	11
Organ transplant patients, COVID‐19, and neutralizing monoclonal antibodies: The glass is half full	11
Shorter is better: The case for short antibiotic courses for common infections in solid organ transplant recipients	11
Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial	11
Kidney transplant from hepatitis C viremic donors into aviremic recipients and risk for post‐transplant BK and cytomegalovirus infection	11
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin	11
Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients	11
Riders on the Storm	10
Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease	10
Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients	10
Surgical site infection due to Mycobacterium fortuitum in a lung transplant recipient	10
Cytomegalovirus‐driven early‐onset lymphocytosis in hematopoietic allogeneic transplant mimicking a T‐cell lymphoma progression	10
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole	10
Seroconversion after COVID‐19 vaccination and heart transplant recipients: Correspondence	10
The ID Digital Institute: Building a digital education toolset and community	10
When you need to dive in the deep end—Transplanting SARS‐CoV‐2 PCR+ recipients	10

Incidence and Timing of Epstein–Barr Virus Whole Blood DNAemia in Epstein–Barr Virus‐Mismatched Adult and Pediatric Solid Organ Transplant Recipients	10
Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center	10
Use of HCV NAT+ donors: A patient's perspective	10
Aspergillus spp. renal arteritis after kidney transplantation: A reappraisal	10
Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons	10
Correction to “Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial”	9
Previous use of statins does not improve the outcome of bloodstream infection after kidney transplantation	9
A rapid point‐of‐care polymerase chain reaction test in suspected viral respiratory tract infection after lung transplantation – A single‐center experience	9
Impact of immunosuppression on the immune response to SARS‐CoV‐2 infection: A mechanistic study	9
	9
Disseminated histoplasmosis with refractory thrombocytopenia in a renal transplant patient	9
Systematic fungal biomarker or polymerase chain reaction testing in lung transplant recipients: Retrospective analysis to optimize their use	9
Donor‐derived infections: Current practice, global strategies, and future challenges	9
A case of severe COVID‐19 despite full vaccination with mRNA‐1273 SARS‐CoV‐2 vaccine (Moderna) in a kidney transplant recipient	9
Revised nucleic acid test window periods: Applications and limitations in organ donation practice	9
	9
Cytomegalovirus reactivation and recalcitrant oral ulcers following coronavirus disease 2019 infection in a kidney transplant recipient	9
Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis	9
QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation	9
Paradoxical outcomes of gram‐negative bloodstream infection in solid organ transplant recipients	9
Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches	9
	9
Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians	9
Extended‐spectrum β‐lactamase‐producing and carbapenem‐resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches	8
Donor‐derived fulminant herpes simplex virus hepatitis after liver transplantation: Two cases and review of literature	8
Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?	8
Road map to success: Advice for transplant infectious diseases job interviews, negotiation, and early career development	8
The intricate interplay of immunosuppression and outcomes following Gram‐negative bloodstream infection in solid organ transplantation	8
Longitudinal impact of COVID‐19 on lung function in lung transplant recipients: Time to stop worrying?	8
Duration of antibiotics in kidney transplant recipients with pyelonephritis: Current practice, research gaps, and future research	8
Prevention and management of infectious and tropical diseases in kidney transplant recipients residing in European outermost and overseas territories	8
Nontuberculous mycobacterial infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation	8
Minocycline‐induced hyperpigmentation in a patient on long‐term Nocardia suppressive treatment	8
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipients	8
Poor hospitalization outcomes in patients undergoing allogeneic hematopoietic stem cell transplant with hospital acquired influenza infection	8
Cytomegalovirus related hospitalization costs among hematopoietic stem cell and solid organ transplant recipients treated with maribavir versus investigator‐assigned therapy: A US‐based study	7
Antibacterial prophylaxis for neutropenic and high‐risk hematology patients—Do the benefits outweigh the risk?	7
Disseminated Mycobacterium abscessus secondary to adult onset immunodeficiency syndrome due to anti‐interferon gamma autoantibodies	7
Disseminated histoplasmosis with central nervous system involvement in a kidney transplant recipient	7
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients	7
Can Quantitative Polymerase Chain Reaction in Tissue Improve Cytomegalovirus Management? Balancing Diagnostic Sensitivity and the Risk of Overtreatment	7
	7
The effectiveness and safety of low dose trimethoprim‐sulfamethoxazole for the treatment of pneumocystis pneumonia: A systematic review and meta‐analysis	7
Hemophagocytic syndrome triggered by donor‐transmitted toxoplasmosis as a complication in same‐donor recipients of renal transplantation: Case report and review of the literature	7
Bridging the Gaps in CMV Management in Transplantation: Lessons From Resource‐Limited Settings	7
	7
Short‐course antibiotic treatment for Gram‐negative bloodstream infection in neutropenic cancer patients: Less is more	7
Infection evaluation in the early period after liver transplantation: A single‐center exploration	7
Breakthrough SARS‐CoV‐2 infections among recipients of tixagevimab‐cilgavimab prophylaxis: A citywide real‐world effectiveness study	7
When a fungal infection is worse than a leukemia diagnosis	7
Majocchi's granuloma in a patient with GATA2 haploinsufficiency undergoing hematopoietic stem cell transplantation	7
Impact of Bebtelovimab Treatment Timing on COVID‐19 Outcomes in Ambulatory Solid Organ Transplant Recipients	7
Use of the QuantiFERON Monitor Assay to Predict Clinical Outcomes in Solid Organ and Hematopoietic Cell Transplant Recipients: A Scoping Review	7
Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With Active Left Neck Tuberculosis: A Case Report	7
Impact of COVID‐19 on abdominal organ transplantation: A bibliometric analysis	7
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023	6
Risk factors and outcomes of BK viremia among deceased donor kidney transplant recipients based on donor characteristics	6
Favorable outcomes of COVID‐19 in vaccinated hematopoietic stem cell transplant recipients: A single‐center experience	6
Organ vigilance in the Middle East: Challenges and prospects	6
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre‐emptive monitoring in the era of letermovir	6
Impact of Pretransplant Antimicrobial Sulfonamide Allergy Label in Kidney Transplant Recipients	6
Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients	6
Infections in patients with primary immunodeficiencies: Insight into infections in secondary immunodeficiency and transplantation	6
	6
Biofire pneumonia panel in lung donors: faster detection but limited pathogens	6
A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy	6
	6
Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy	6
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept	6
Post‐transplant lymphoproliferative disorder in pediatric liver transplant recipients: Experience from a South African transplant center	6
Delayed diagnosis and treatment of secondary syphilis in pancreas–kidney transplant recipient: Need for increased awareness of sexually transmitted infections in solid organ transplantation	6
Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis	6
“They paged me what?”: A transplant infectious disease guide to donor calls	6
Hepatic granulomas in a pediatric liver transplant recipient	6
	6
Cell‐free next‐generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study	6
Bacterial genotype and clinical outcomes in solid organ transplant recipients with Staphylococcus aureus bacteremia	6
Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee	6
Social Media Savvy, It's More Than Just the #Hashtags: How the Use of Social Media in Transplant Infectious Diseases Can Impact the Field and Patients	6
Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants	6

Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients	6
Comment on: mRNA SARS‐CoV‐2 vaccination in patients after allogeneic hematopoietic cell transplantation	6
Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients	6
Crusted Scabies with Facial Involvement in a Patient Following Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report	6
	6
Current state of antimicrobial stewardship and organ transplantation in Saudi Arabia	5
Potential donor characteristics and decisions made by organ procurement organization staff: Results of a discrete choice experiment	5
The nuts and bolts of transplant infectious disease training	5
Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high‐risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves	5
Investigation of donor‐derived Strongyloides stercoralis infection in multiple solid organ transplant recipients—California, Michigan, Ohio, 2022	5
COVID‐19 in heart transplant recipients: Outcomes according to vaccination status	5
Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation	5
Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual	5
Recurrent Outbreak of Carbapenem‐Resistant IMP‐1‐Producing Pseudomonas aeruginosa in Kidney Transplant Recipients: The Impact of Prolonged Patient Colonization	5
Transplant Infectious Disease Training: Bridging the Gap	5
Moving xenotransplantation from bench to bedside: Managing infectious risk	5
Minding the gap: How transplant infectious disease can help close the organ donation gap	5
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis	5
Antimicrobial stewardship for organ donors: Importance, current practice, and challenges	5
Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients	5
Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review	5
Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey	5
Issue Information	5
Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?	5
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non‐renal solid organ transplant recipients?	5
Daptomycin‐associated pulmonary toxicity sans eosinophilia in a hematopoietic cell transplant recipient with profound leukopenia	5
Letermovir for pre‐emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation	5
Donor blood cultures and outcomes after lung transplantation: a single‐center report	5
Re: Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis against Multidrug‐Resistant Bacteria	5
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria	5
Pseudomonal blepharoconjunctivitis causing neutropenic sepsis after allogeneic hematopoietic cell transplantation	5
Clinical characteristics of COVID‐19 in solid organ transplant recipients following COVID‐19 vaccination: A multicenter case series	5
	5
Disseminated Blastomycosis Presenting With Skin Lesions in a Renal Transplant Recipient	5
Use of live viral vaccines after HCT: Still a lot to learn	5
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances	5
Beta‐lactam allergies, surgical site infections, and prophylaxis in solid organ transplant recipients at a single center: A retrospective cohort study	5
Cefiderocol utilization in lung transplant recipients at a single center	5
Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV‐related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA	5
Impact of high MELD scores on CMV viremia following liver transplantation	5
Effect of Antibiotics With Anaerobic Coverage on Graft‐Versus‐Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis	5
Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid org	5
Comparative analysis and trends in liver transplant hospitalizations with Clostridium difficile infections: A 10‐year national cross‐sectional study	5
Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation – A retrospective single‐center study	5
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients – A retrospective matched cohort study	5
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch	5
Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma	4
Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant	4
Hemorrhage Incognito	4
Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with SARS‐CoV‐2 infection: Correspondence	4
Multi‐drug resistant and rifampin‐resistant tuberculosis in transplant recipients	4
Auditing tools for antimicrobial prescribing in solid organ transplant recipients: The why, the how, and an assessment of current options	4
Is diagnostic stewardship possible in solid organ transplantation?	4
Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis	4
	4
Outcomes of SARS‐CoV‐2 infection among lung transplant recipients: A single center retrospective study	4
The cascade of care in testing and treatment of latent tuberculosis infection in liver transplant candidates	4
Infections are No Holiday	4
Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates	4
A Scoping Review of Arthropod‐Borne Flavivirus Infections in Solid Organ Transplant Recipients	4
	4
Addressing the Rising Burden of Carbapenemase‐Producing Enterobacterales in Liver Transplant Recipients: A Call for Enhanced Surveillance and Prevention Strategies	4
Issue Information	4
Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival	4
Transplantation and immigration: Comparing infectious complications and outcomes between foreign‐born and US‐born kidney transplant recipients in Minnesota	4
Issue Information	4
Safety and efficacy of one and two booster doses of SARS‐CoV‐2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial	4
Issue Information	4
BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathy	4
Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct‐acting antiviral therapies	4
Antibiotic Exposure and Risk of Allograft Rejection and Survival After Liver Transplant: An Observational Cohort Study From a Tertiary Referral Centre	4
Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies	4
Management of vancomycin‐resistant Enterococci and daptomycin‐resistant Enterococci infections in liver transplant recipients in a single academic center	4
The black urine challenge	4
Outcomes of transplant recipients with pretransplant Nocardia colonization or infection	4
	4
Critical Insights: Severe Outcomes of Pneumocystis Pneumonia: A 10‐year Retrospective Cohort Study	4
Use of anti‐CMV immunoglobulins in lung transplant recipients: The French experience	4
Changing the culture of blood cultures: Opportunities for diagnostic stewardship in febrile neutropenia	4
Favorable experience of transplant strategy including liver grafts from COVID‐19 donors: One‐year follow‐up results	4
Antimicrobial stewardship in solid organ transplant—Opportunities in the National Health Service	4
Comment on “Re‐infection with SARS‐CoV‐2 in solid‐organ transplant recipients”	4
Metronidazole‐induced encephalopathy after living donor liver transplantation	4
Organ donation and HIV: Awareness and willingness to be a living donor among people with HIV in Uganda	4
Transplantation of organs from SARS‐CoV‐2‐positive donors: Preliminary experience from Spain	4
Postexposure prophylaxis after receipt of MMR vaccine prior to emergent heart transplant	4
Impact of donor multidrug‐resistant organisms on solid organ transplant recipient outcomes	4
Donor‐derived strongyloidiasis: The beginning of the end?	4
Multifocal cutaneous Mycobacterium ulcerans infection in a heart transplant recipient	4
Deceased Donor Infectious Diseases Testing and Antimicrobial Use: Surveys of Organ Procurement Organizations and Transplant Professionals	4
Risk and benefits of expanded donor screening: A viewpoint from Germany	4
Central nervous system infection with Hantavirus in a solid organ transplant patient	4
	4
Desirability of outcome ranking and quality life measurement for antimicrobial research in organ transplantation	4
Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship	4